• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Mixed; Cigna Shares Spike Higher

    12/11/23 10:20:54 AM ET
    $CI
    $COGT
    $CYTO
    $HUM
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CI alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 20 points on Monday.

    Following the market opening Monday, the Dow traded up 0.07% to 36,272.54 while the NASDAQ fell 0.26% to 14,366.24. The S&P 500 also fell, dropping, 0.02% to 4,603.60.

    Check This Out: This Analyst With 84% Accuracy Rate Sees More Than 7% Upside In Broadcom - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

     

    Leading and Lagging Sectors

     

    Industrials shares rose by 0.7% on Monday.

    In trading on Monday, communication services shares fell by 1.4%.

     

    Top Headline

     

    Shares of Cigna Group (NYSE:CI) traded higher on Monday after the company reportedly ended its attempt to negotiate an acquisition deal with rival Humana Inc (NYSE:HUM) after the pair disagreed on price terms.

     

    Equities Trading UP

     

    Pasithea Therapeutics Corp. (NASDAQ:KTTA) shares shot up 130% to $0.7012 after the company announced preclinical results from two in vivo studies evaluating the antitumor efficacy of PAS-004 in NRAS mutation cancer xenograft models.

    Shares of Assure Holdings Corp. (NASDAQ:IONM) got a boost, shooting 82% to $0.6384.

    NextPlay Technologies, Inc. (NASDAQ:NXTP) shares were also up, gaining 70% to $0.7136 on continued volatility after the company last week received notification for not meeting the deadline to file its financial reports for several periods in 2023.

     

    Equities Trading DOWN

     

    Cogent Biosciences, Inc. (NASDAQ:COGT) shares dropped 51% to $4.2600 after the company reported initial data from its ongoing Phase 2 SUMMIT trial and data from Part 1 of its ongoing Phase 2 APEX clinical at ASH 2023.

    Shares of Altamira Therapeutics Ltd. (NASDAQ:CYTO) were down 44% to $0.2298 after the company issued investor and business update. The company's board has decided to effect a 20-for-1 reverse stock split on Dec. 13, 2023.

    Near Intelligence, Inc. (NASDAQ:NIR) was down, falling 43% to $0.0864. Near Intelligence filed for Chapter 11 protection and entered into agreement to sell its business.

    Also Check This Out: Alphabet, Best Buy And 2 Other Stocks Insiders Are Selling

     

    Commodities

     

    In commodity news, oil traded down 0.4% to $70.94 while gold traded down 0.6% at $2,002.40.

    Silver traded down 0.7% to $23.115 on Monday while copper fell 1.4% to $3.7765.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 rose 0.2%, London’s FTSE 100 fell 0.2% while Spain’s IBEX 35 Index fell 0.4% The German DAX gained 0.1% French CAC 40 gained 0.3%, while Italy’s FTSE MIB Index rose 0.1%.

     

    Asia Pacific Markets

     

    Asian markets closed mostly higher on Monday, with Japan’s Nikkei 225 gaining 1.50%, Hong Kong’s Hang Seng Index falling 0.81% and China’s Shanghai Composite Index gaining 0.74%. India’s S&P BSE Sensex, meanwhile, rose 0.15%.

    Japan’s machine tool orders fell 13.6% year-over-year to JPY 115,884 million in November versus a 20.6% plunge in October. The business survey index of large manufacturing firms in Japan accelerated to 5.7% in the fourth quarter from 5.4% in the prior quarter.

    China's producer prices fell by 3.0% year-over-year in November versus a 2.6% decline in the previous month, while consumer prices fell by 0.5% year-over-year in November.

     

    Economics

     

    There were no major US economic releases Monday.

    Now Read This: Top 5 Tech And Telecom Stocks That Are Set To Fly In Q4

    Get the next $CI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CI
    $COGT
    $CYTO
    $HUM

    CompanyDatePrice TargetRatingAnalyst
    Cogent Biosciences Inc.
    $COGT
    3/16/2026Buy
    Jefferies
    The Cigna Group
    $CI
    3/12/2026$358.00Mkt Perform → Outperform
    Bernstein
    Humana Inc.
    $HUM
    2/12/2026$189.00Outperform → Sector Perform
    RBC Capital Mkts
    Humana Inc.
    $HUM
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    Humana Inc.
    $HUM
    1/7/2026$290.00Overweight → Equal Weight
    Wells Fargo
    Humana Inc.
    $HUM
    12/5/2025$313.00Hold → Buy
    Jefferies
    Cogent Biosciences Inc.
    $COGT
    11/10/2025$40.00Hold → Buy
    Stifel
    Cogent Biosciences Inc.
    $COGT
    11/10/2025$38.00Neutral → Outperform
    Wedbush
    More analyst ratings

    $CI
    $COGT
    $CYTO
    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, CenterWell Shetty Sanjay K bought $150,016 worth of Humana Common (810 units at $185.21), increasing direct ownership by 7% to 11,657 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/25/26 11:48:38 AM ET
    $HUM
    Medical Specialities
    Health Care

    Director Steinman Lawrence bought $100,000 worth of shares (133,333 units at $0.75), increasing direct ownership by 201% to 199,691 units (SEC Form 4)

    4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)

    12/1/25 9:07:14 AM ET
    $KTTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Marques Tiago bought $25,000 worth of shares (33,333 units at $0.75), increasing direct ownership by 83% to 73,334 units (SEC Form 4)

    4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)

    12/1/25 8:56:56 AM ET
    $KTTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CI
    $COGT
    $CYTO
    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Cigna Group Declares Quarterly Dividend

    BLOOMFIELD, Conn., April 22, 2026 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.56 per share of its common stock, payable on June 18, 2026, to shareholders of record as of the close of business on June 4, 2026. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services mar

    4/22/26 4:30:00 PM ET
    $CI
    Medical Specialities
    Health Care

    Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

    WALTHAM, Mass. and BOULDER, Colo., April 21, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (NASDAQ:COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that the results from the Phase 3 PEAK trial have been selected for oral presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, being held in Chicago, IL, May 29-June 2, 2026. The presentation will feature data from the positive trial of bezuclastinib in combination with sunitinib in patients with Gastrointestinal Stromal Tumors (GIST) who have received prior treatment with imatinib. Top line results were reported in November 2025, and t

    4/21/26 8:00:00 AM ET
    $COGT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CenterWell Introduces the Fulfillment Index, a New Measure of What It Means to Age Well

    The CenterWell Fulfillment Index offers a new way to understand what drives wellbeing as people age CenterWell, the health care services business of Humana Inc. (NYSE:HUM), today introduced the CenterWell Fulfillment Index, a new national measure to better understand what drives wellbeing as people age. The research reinforces that aging well is more than physical health alone, and that factors like purpose, emotional stability, connection, comfort, independence and security play an important role in how older adults experience their lives. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420973797/en/ The CenterWell Fulfillm

    4/20/26 8:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $COGT
    $CYTO
    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Field Robert Stuart

    3 - HUMANA INC (0000049071) (Issuer)

    4/21/26 10:09:50 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Coastlands Capital Lp

    3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)

    4/17/26 9:45:12 PM ET
    $KTTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Nelson Andrea L

    3 - Cigna Group (0001739940) (Issuer)

    4/3/26 5:13:56 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    $COGT
    $CYTO
    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on Cogent Biosciences

    Jefferies resumed coverage of Cogent Biosciences with a rating of Buy

    3/16/26 9:35:47 AM ET
    $COGT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Cigna Group upgraded by Bernstein with a new price target

    Bernstein upgraded The Cigna Group from Mkt Perform to Outperform and set a new price target of $358.00

    3/12/26 8:38:26 AM ET
    $CI
    Medical Specialities
    Health Care

    Humana downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Humana from Outperform to Sector Perform and set a new price target of $189.00

    2/12/26 8:16:45 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $COGT
    $CYTO
    $HUM
    SEC Filings

    View All

    SEC Form DEFA14A filed by Cogent Biosciences Inc.

    DEFA14A - Cogent Biosciences, Inc. (0001622229) (Filer)

    4/23/26 4:33:21 PM ET
    $COGT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Cogent Biosciences Inc.

    DEF 14A - Cogent Biosciences, Inc. (0001622229) (Filer)

    4/23/26 4:30:56 PM ET
    $COGT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Humana Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - HUMANA INC (0000049071) (Filer)

    4/20/26 4:31:18 PM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $COGT
    $CYTO
    $HUM
    Leadership Updates

    Live Leadership Updates

    View All

    The Cigna Group Announces President & COO Brian Evanko to Succeed David M. Cordani as Chief Executive Officer

    Cordani to retire as chief executive officer on July 1, 2026, and will serve as executive chair of The Cigna Group Board of DirectorsEvanko elected to the company's Board of DirectorsCompany reaffirms 2026 Financial OutlookBLOOMFIELD, Conn., March 3, 2026 /PRNewswire/ -- The Cigna Group (NYSE: CI) today announced that David M. Cordani will retire as chief executive officer effective July 1, 2026, and become executive chair of The Cigna Group's Board of Directors. Brian Evanko, current president and chief operating officer, will succeed Cordani as CEO. Throughout his tenure—inclu

    3/3/26 7:30:00 AM ET
    $CI
    Medical Specialities
    Health Care

    VINCENT COUNTRY SAFE ZONE ACTIVITY DAY PRESENTED BY CIGNA HEALTHCARE DELIVERS SUPER BOWL WEEK FUN, NFL FLAG FOOTBALL, AND WELLNESS TO OAKLAND STUDENTS

    Corporate, Nonprofit, and Philanthropic Partners Collaborated to Provide Transformative Experiences and Lasting Resources at Burckhalter Elementary School OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare, a flagship initiative of Love Thy Neighbor CDC co-founded by NFL Executive and Legend Troy Vincent, Sr. and his wife, author and chef Tommi A. Vincent, took place Tuesday, February 3, at Burckhalter Elementary School in Oakland, CA. The ninth annual event, themed Dreams Grow Here, delivered a full day of fun, food, wellness, and engaging sports activities, including NFL FLAG, for more than 200 Pre-K through fifth-grade studen

    2/3/26 8:17:00 PM ET
    $CI
    Medical Specialities
    Health Care

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $CI
    $COGT
    $CYTO
    $HUM
    Financials

    Live finance-specific insights

    View All

    The Cigna Group Declares Quarterly Dividend

    BLOOMFIELD, Conn., April 22, 2026 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.56 per share of its common stock, payable on June 18, 2026, to shareholders of record as of the close of business on June 4, 2026. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services mar

    4/22/26 4:30:00 PM ET
    $CI
    Medical Specialities
    Health Care

    Humana Board Declares Payment of Quarterly Dividend to Stockholders

    Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 31, 2026 to stockholders of record as of the close of business on June 26, 2026. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Le

    4/15/26 5:00:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    The Cigna Group's First Quarter 2026 Earnings Release Details

    BLOOMFIELD, Conn., April 2, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2026 financial results on Thursday, April 30, 2026, and will host a conference call the same day. First quarter 2026 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:Live Call(888) 566-1889 (Domestic)(773) 799-3989 (International)Passcode: 04302026Replay(866) 405-7290 (Domestic)(203) 369-0603 (International

    4/2/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    $COGT
    $CYTO
    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cogent Biosciences Inc.

    SC 13G/A - Cogent Biosciences, Inc. (0001622229) (Subject)

    11/14/24 7:59:55 PM ET
    $COGT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cogent Biosciences Inc.

    SC 13G/A - Cogent Biosciences, Inc. (0001622229) (Subject)

    11/14/24 5:47:15 PM ET
    $COGT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cogent Biosciences Inc.

    SC 13G/A - Cogent Biosciences, Inc. (0001622229) (Subject)

    11/14/24 4:05:10 PM ET
    $COGT
    Biotechnology: Pharmaceutical Preparations
    Health Care